But behind the headlines and hashtags lies a disturbing trend that deserves urgent attention: the rise of compounded GLP-1s ...

The U.S. Food and Drug Administration (FDA) already declared that shortages of popular GLP-1 medications have ended, CNN reported. Those medications include semaglutide (Ozempic and Wegovy) and ...

MBX Biosciences is advancing a unique prodrug pipeline with key GLP-1 assets and a pivotal Phase 2 readout in ...

GLP-1 stands for glucagon-like peptide-1, a satiety hormone the body produces when we eat to help stimulate digestion and ...

As the Food and Drug Administration clamps down on off-brand weight loss medications, Seattle-area residents are stocking up ...

The FDA has been cut off from producing compounded weight-loss drugs such as Ozempic, Mounjaro or Wegovy, the most effective ...

A San Antonio weight loss clinic owner is encouraging consumers of the GLP-1 drug semaglutide not to panic now that the FDA ...

Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.

Compounding pharmacies, that produced the weight loss drugs at a fraction of their brand name price, are being forced to stop ...

But the FDA declared months ago that the shortages of semaglutide and tirzepatide injections had ended, effectively ending ...

Compounding is when a licensed pharmacist ... each of adverse effects from compounded semaglutide and compounded tirzepatide. But the agency noted that “federal law does not require state ...

Compounding pharmacies had been producing ... The grace period for producing and selling compounded tirzepatide ended in March. Thursday was the final cut-off for compounded semaglutide.